BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31735782)

  • 1. Effect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome.
    Kim BS; Eom SY; Kim SH; Hwang HK; Park JS; Kim W; Lee JW; Rha SW; Kim GY; Lim SW; Lee SH; Chae JK; Woo SI; Bae JW; Kim HJ
    Int Heart J; 2019 Nov; 60(6):1284-1292. PubMed ID: 31735782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Park J; Han JK; Kang J; Chae IH; Lee SY; Choi YJ; Rhew JY; Rha SW; Shin ES; Woo SI; Lee HC; Chun KJ; Kim DI; Jeong JO; Bae JW; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
    Am J Cardiol; 2020 Dec; 137():12-19. PubMed ID: 32998005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry.
    D'Ascenzo F; Celentani D; Brustio A; Grosso A; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Kedev S; Moretti C; D'Amico M; Gaita F
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):299-309. PubMed ID: 29691803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impacts of β-blockers in acute coronary syndrome patients without heart failure treated by percutaneous coronary intervention.
    Chen RZ; Liu C; Zhou P; Li JN; Zhou JY; Wang Y; Zhao XX; Chen Y; Song L; Zhao HJ; Yan HB
    Pharmacol Res; 2021 Jul; 169():105614. PubMed ID: 33872810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of multivessel percutaneous coronary intervention and coronary artery bypass grafting in patients with severe coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes.
    Desperak P; Hawranek M; Hrapkowicz T; Zembala MO; Gąsior M
    Kardiol Pol; 2018; 76(10):1474-1481. PubMed ID: 30251246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.
    Ozasa N; Kimura T; Morimoto T; Hou H; Tamura T; Shizuta S; Nakagawa Y; Furukawa Y; Hayashi Y; Nakao K; Matsuzaki M; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2010 Nov; 106(9):1225-33. PubMed ID: 21029817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
    Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
    EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of Vasodilating β-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study.
    Chung J; Han JK; Kim YJ; Kim CJ; Ahn Y; Chan Cho M; Chae SC; Chae IH; Chae JK; Seong IW; Yang HM; Park KW; Kang HJ; Koo BK; Jeong MH; Kim HS;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.
    Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Thrombus Aspiration for Patients With Acute Coronary Syndrome: Insights From the Nationwide J-PCI Registry.
    Inohara T; Kohsaka S; Yamaji K; Iida O; Shinke T; Sakakura K; Ishii H; Amano T; Ikari Y
    J Am Heart Assoc; 2022 Aug; 11(16):e025728. PubMed ID: 35946472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.
    Inohara T; Kohsaka S; Miyata H; Sawano M; Ueda I; Maekawa Y; Fukuda K; Jones PG; Cohen DJ; Zhao Z; Spertus JA; Smolderen KG
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Danlou Tablet () on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial.
    Wang L; Mao S; Qi JY; Ren Y; Guo XF; Chen KJ; Zhang MZ
    Chin J Integr Med; 2015 Sep; 21(9):662-6. PubMed ID: 26142341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
    Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
    Int J Cardiol; 2013 Jul; 166(3):596-600. PubMed ID: 22192297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital outcome in patients presenting with acute coronary syndrome with left main coronary artery disease: A report from Japanese prospective multicenter percutaneous coronary intervention registry.
    Tani H; Sawano M; Numasawa Y; Kobayashi Y; Suzuki M; Noma S; Shiraishi Y; Ueda I; Fukuda K; Kohsaka S
    J Cardiol; 2020 Jun; 75(6):635-640. PubMed ID: 31899113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Differences in Percutaneous Coronary Intervention-Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology.
    Heer T; Hochadel M; Schmidt K; Mehilli J; Zahn R; Kuck KH; Hamm C; Böhm M; Ertl G; Hoffmeister HM; Sack S; Senges J; Massberg S; Gitt AK; Zeymer U
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis.
    Vercellino M; Sànchez FA; Boasi V; Perri D; Tacchi C; Secco GG; Cattunar S; Pistis G; Mascelli G
    BMC Cardiovasc Disord; 2017 Apr; 17(1):97. PubMed ID: 28381298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.